Biohazards - EBOLA

EBOLA  (chronology) is a member of the Filoviruses family in the Viral Hemorrhagic Fevers (VHFs) category.  The latest outbreak of Ebola began March 2014 and continues but at a decreasing rate.  CDC figures as of July 10, 2015 are:

Cases (suspected, probable and confirmed)     27,636
Laboratory Confirmed     15,159
Total Deaths     11,268

CDC has stated that symtoms may appear anywhere from 2 to 21 days after exposure to the Ebola virus though 8-10 days has been most common.

Mapp Biopharmaceuticals was among the first to respond with a new treatment.  Little is published about Mapp which may indicate some military funding.  Mapp developed experimental ZMAPP which has been given to Dr. Kent Brantly and Nancy Whiteboi - both have recovered.  Other experimental drug treatments have been given other patients.  It must be stressed that expermental drugs long term effectiveness, impact and side effects on a human are not established.

Can the Ebola virus be totally removed from recovered patients?  One disturbing discovery...

References:     CDC     WHO